Cirex Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1990.
1990 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Cirex Pharmaceuticals Private Limited

Cirex Pharmaceuticals Private Limited, a active private limited company, was established on 21 December 1990 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1990PTC012119. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.15 Cr.

Formerly known as Cirex Pharmaceuticals Limited, Scirex Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Navin Kumar Reddy Puchakayala (Director), Chandra Sekhar Tumuluru (Director). Past directors included Viswanadha Raju Penmatsa, Bandi Vamsikrishna, Navin Kumar Reddy Puchakayala. It holds no open charges and ₹109.73 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No. 8-3-166/7/1, Erragadda, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1990PTC012119

  • Registration Number

    012119

  • Incorporation Date

    21 December 1990

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.15 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.15 Cr
  • Company Age 35 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 109.73 Cr
  • Revenue Growth **** -95.53%
  • Profit Growth **** -81.36%
  • Ebitda **** -100.22%
  • Net Worth 0.75%
  • Total Assets -16.91%
Company report

Cirex Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cirex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cirex Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Navin Kumar Reddy Puchakayala Director 17 Jun 2021 Current
Chandra Sekhar Tumuluru Director 14 Jul 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2009 Past
Pramod Abcsdd Director 15 Jul 2015 Past
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Additional Director 17 Sep 2015 Past
Pramod Abcsdd Director 31 Mar 2014 Past
Pramod Abcsdd Director 22 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cirex Pharmaceuticals.

Cirex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.53% decrease. The company also saw a substantial fall in profitability, with a 81.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.75%.

Cirex Pharmaceuticals revenue growth over time
Cirex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -95.53%
*******
*******
*******
*******
Revenue from Operations
*******
 -98.82%
*******
*******
*******
*******
Total Assets
*******
 -16.91%
*******
*******
*******
*******
Profit or Loss
*******
 -81.36%
*******
*******
*******
*******
Net Worth
*******
 0.75%
*******
*******
*******
*******
EBITDA
*******
 -100.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cirex Pharmaceuticals?

In 2023, Cirex Pharmaceuticals had a promoter holding of 95.86% and a public holding of 4.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,097,300,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of Hyderabad : 108.50 Cr
  • Andhra Pradesh State Financial Corporation : 0.62 Cr
  • Ap State Financial Corporation : 0.56 Cr
  • Indian Overseas Bank : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
21 May 2009 State Bank Of Hyderabad ₹74.00 Cr Satisfied
09 Feb 2001 State Bank Of Hyderabad ₹34.50 Cr Satisfied
29 Mar 1995 Indian Overseas Bank ₹0.50 M Satisfied
20 Mar 1995 Ap State Financial Corporation ₹5.58 M Satisfied
22 Mar 1991 Andhra Pradesh State Financial Corporation ₹6.22 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cirex Pharmaceuticals?

Cirex Pharmaceuticals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cirex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cirex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cirex Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cirex Pharmaceuticals Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Cirex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Navin Kumar Reddy Puchakayala was appointed as a Director was appointed as a Director on 17 Jun 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 21 May 2009 via Charge ID 10163194 with State Bank Of Hyderabad was fully satisfied on 03 Dec 2015. was documented.

  • Charges

    Progress on A charge registered on 09 Feb 2001 via Charge ID 90124225 with State Bank Of Hyderabad was fully satisfied on 03 Dec 2015. was documented.

  • Director Appointment

    Chandra Sekhar Tumuluru was appointed as a Director was appointed as a Director on 14 Jul 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cirex Pharmaceuticals Private Limited?

The CIN of Cirex Pharmaceuticals Private Limited is U24239TG1990PTC012119.

Where is Cirex Pharmaceuticals Private Limited headquartered?

Cirex Pharmaceuticals Private Limited is headquartered at H.No. 8-3-166/7/1, Erragadda, Hyderabad, Telangana, 500018.

When was Cirex Pharmaceuticals Private Limited incorporated?

Cirex Pharmaceuticals Private Limited was incorporated on 21 December 1990.

Who are the current directors of Cirex Pharmaceuticals Private Limited?

The current directors of Cirex Pharmaceuticals Private Limited are

What is the primary industry of Cirex Pharmaceuticals Private Limited?

The primary industry of Cirex Pharmaceuticals Private Limited is Manufacturing.

Is Cirex Pharmaceuticals Private Limited a listed company?

Cirex Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Cirex Pharmaceuticals Private Limited?

The authorized capital of Cirex Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.15 Cr.

What is the compliance status of Cirex Pharmaceuticals Private Limited?

The compliance status of Cirex Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available